2023
DOI: 10.1016/j.intimp.2023.110229
|View full text |Cite
|
Sign up to set email alerts
|

Parthenolide targets NLRP3 to treat inflammasome-related diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 54 publications
0
6
0
Order By: Relevance
“…We performed H&E staining and PAS staining to identify the pathological changes in lung inflammation and mucus production after treatment with TVE in NA mouse model. As shown in Figure 6B, an accumulation of infiltrated cells was observed around the airways in the lung tissue of the NA mouse model, 38 whereas the number of infiltrating cells was significantly reduced in the lung tissue upon treatment with TVE or MCC950. Similarly, the analysis of the mucus produced by airway epithelial cells in the PAS staining experiment revealed a significant increase in mucus in the NA model; however, treatment with TVE or MCC950 strongly inhibited mucus production (Figure 6B).…”
Section: Resultsmentioning
confidence: 86%
See 1 more Smart Citation
“…We performed H&E staining and PAS staining to identify the pathological changes in lung inflammation and mucus production after treatment with TVE in NA mouse model. As shown in Figure 6B, an accumulation of infiltrated cells was observed around the airways in the lung tissue of the NA mouse model, 38 whereas the number of infiltrating cells was significantly reduced in the lung tissue upon treatment with TVE or MCC950. Similarly, the analysis of the mucus produced by airway epithelial cells in the PAS staining experiment revealed a significant increase in mucus in the NA model; however, treatment with TVE or MCC950 strongly inhibited mucus production (Figure 6B).…”
Section: Resultsmentioning
confidence: 86%
“…One-way ANOVA, Bonferroni post-hoc test; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, n.s. not significant.of the NA mouse model,38 whereas the number of infiltrating cells was significantly reduced in the lung tissue upon treatment with TVE or MCC950. Similarly, the analysis of the mucus produced by airway epithelial cells in the PAS staining experiment revealed a significant increase in mucus in the NA model; however, treatment with TVE or MCC950 strongly inhibited mucus production (Figure6B).…”
mentioning
confidence: 90%
“…Studies have also shown that parthenolide has potential therapeutic effects for conditions such as leukemia, Alzheimer’s disease, and migraines ( Materazzi et al, 2013 ; Yang et al, 2017 ; Fan et al, 2023 ). In addition to these diseases, parthenolide has promising effects on diabetes and its related complications ( Liu et al, 2023b ). Mounting evidence also has established a close relationship between VDR signaling and diabetes, as well as diabetic nephropathy and insulin resistance.…”
Section: Natural Bioactive Compounds Targeting Vdr Activitymentioning
confidence: 99%
“…The wide range of biological activities shown by PTL is mainly attributed to the α-exo-methylene-γ-butyrolactone moiety present in its structure [4,5]. In fact, α-exo-methylene is able to react with nucleophilic cysteines from biomolecules through a Michael addition (Figure 1) [6][7][8] to form a covalent bond.…”
Section: Introductionmentioning
confidence: 99%
“…structure [4,5]. In fact, α-exo-methylene is able to react with nucleophilic cysteines from biomolecules through a Michael addition (Figure 1) [6][7][8] to form a covalent bond.…”
Section: Introductionmentioning
confidence: 99%